A Comparison of Toxicity Profile of Gemcitabine Monotherapy Versus Etoposide/Cisplatin in the Treatment of Locally Advanced or Metastatic Non-Small Cell Lung Cancer

International Journal of Basic & Clinical Pharmacology
doi 10.5455/2319-2003.ijbcp20150213
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Medip Academy

Related search

162P: Molecular Markers in Advanced Non Small Cell Lung Cancer Patients Receiving Gemcitabine & Cisplatin

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2016English

Profile of Ramucirumab in the Treatment of Metastatic Non-Small-Cell Lung Cancer

OncoTargets and Therapy
OncologyPharmacology
2016English

Fixed Dose Rate Versus Standard Dose Rate Infusion of Gemcitabine and Cisplatin in Advanced Stage Non-Small Cell Lung Cancer

Journal of Cancer Therapy
2015English

Pcn176 - A Cost-Effectiveness Analysis of Atezolizumab Versus Docetaxel for Previously Treated Locally Advanced or Metastatic Non-Small Cell Lung Cancer in Belgium

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Phase I and Pharmacokinetic Study of Pemetrexed Plus Cisplatin in Chemonaive Patients With Locally Advanced or Metastatic Malignant Pleural Mesothelioma or Non-Small Cell Lung Cancer

Clinical Cancer Research
Cancer ResearchOncology
2009English

Metastatic Non-Small-Cell Lung Cancer and the Use of Gemcitabine During Pregnancy

Journal of Perinatology
GynecologyChild HealthPediatricsPerinatologyObstetrics
2008English

OA02.01 Efficacy and Safety of Entrectinib in Locally Advanced or Metastatic ROS1 Fusion-Positive Non-Small Cell Lung Cancer (NSCLC)

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Randomized Phase II Trial of Cisplatin, Etoposide, and Radiation Followed by Gemcitabine Alone or by Combined Gemcitabine and Docetaxel in Stage III a/B Unresectable Non-Small Cell Lung Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2010English

Algorithm for the Treatment of Advanced or Metastatic Squamous Non-Small-Cell Lung Cancer: An Evidence-Based Overview

Current Oncology
Oncology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy